Depreciation of Century Therapeutics, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Century Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Century Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $3,129,000, a 5.1% decline year-over-year.
  • Century Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $12,870,000, a 4.9% decline year-over-year.
  • Century Therapeutics, Inc. annual Depreciation for 2024 was $13,304,000, a 2% increase from 2023.
  • Century Therapeutics, Inc. annual Depreciation for 2023 was $13,044,000, a 55% increase from 2022.
  • Century Therapeutics, Inc. annual Depreciation for 2022 was $8,440,000, a 125% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Century Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $12,870,000 $3,129,000 -$168,000 -5.1% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $13,038,000 $3,201,000 -$261,000 -7.5% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $13,299,000 $3,221,000 -$5,000 -0.16% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $13,304,000 $3,319,000 -$233,000 -6.6% 01 Oct 2024 31 Dec 2024 10-K 19 Mar 2025 2024 FY
Q3 2024 $13,537,000 $3,297,000 -$53,000 -1.6% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $13,590,000 $3,462,000 +$228,000 +7% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $13,362,000 $3,226,000 +$318,000 +11% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $13,044,000 $3,552,000 +$714,000 +25% 01 Oct 2023 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q3 2023 $12,330,000 $3,350,000 +$576,000 +21% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $11,754,000 $3,234,000 +$1,566,000 +94% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $10,188,000 $2,908,000 +$1,748,000 +151% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $8,440,000 $2,838,000 +$1,787,000 +170% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $6,653,000 $2,774,000 +$1,730,000 +166% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $4,923,000 $1,668,000 +$733,000 +78% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $4,190,000 $1,160,000 +$442,000 +62% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $3,748,000 $1,051,000 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $1,044,000 +$634,000 +155% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $935,000 +$653,000 +232% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $718,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 $410,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $282,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2

Century Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,304,000 +$260,000 +2% 01 Jan 2024 31 Dec 2024 10-K 19 Mar 2025 2024 FY
2023 $13,044,000 +$4,604,000 +55% 01 Jan 2023 31 Dec 2023 10-K 19 Mar 2025 2024 FY
2022 $8,440,000 +$4,692,000 +125% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $3,748,000 +$2,346,000 +167% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $1,402,000 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.